DNMT1 maintains the methylation of miR ‐152‐3p to regulate TMSB10 expression, thereby affecting the biological characteristics of colorectal cancer cells

ConclusionThe study highlights that silenced DNMT1 results in non ‐methylated miR‐152‐3p to depress TMSB10 expression, thereby inhibiting CRC development, which provides a new approach for CRC therapy.

Source: IUBMB Life - September 11, 2020 Category: Research Authors: Chenchen Wang, Xiaoji Ma, Jieyun Zhang, Xiaobin Jia, Mingzhu Huang Tags: RESEARCH COMMUNICATION Source Type: research